Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Login Sign up free
Home Stock ScreenerScreener ETF ScreenerETF Maps Charts News Groups Insider Futures Forex Crypto Watchlist Portfolio Calendar
Pricing

KRMD

KORU Medical Systems Inc

Last Close
3.16
Nov 10 • 3:59 PM ET Dollar change-0.07 Percentage change(-2.17%)
Aftermarket Close
3.41
Aftermarket • 7:59 PM ET Dollar change+0.25 Percentage change(7.91%)
Overview Compare Short Interest Financials Options Filings Dilution
Healthcare Medical Instruments & Supplies USA Micro NASD
Nov 10, 6:48 PMKORU Medical Systems beats Q3 estimates with 11% revenue growth, margin expansion and higher 2026 outlook on Q4 reacceleration
Peers: INFU ICUI EMBC WST MLSS RVP TNDM UTMD PODD ELMD
 | Held by: IWM VTI IWO VXF VTWO IWC GSSC VTWG RSSL OMFS
Scroll to Statements
Index
RUT
Market Cap
145.91M
Enterprise Value
140.93M
Income
-1.82M
Sales
45.11M
Book/sh
0.39
Cash/sh
0.18
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
73
IPO
Apr 05, 1994
P/E
-
Forward P/E
153.03
PEG
-
P/S
3.23
P/B
8.08
P/C
17.60
P/FCF
187.06
EV/EBITDA
-
EV/Sales
3.12
Quick Ratio
2.09
Current Ratio
2.72
Debt/Eq
0.18
LT Debt/Eq
0.15
Option/Short
Yes / Yes
EPS (ttm)
-0.04
EPS next Y
0.02
EPS next Q
-0.01
EPS this Y
34.88%
EPS next Y
152.85%
EPS next 5Y
-
EPS past 3/5Y
33.31% -14.59%
Sales past 3/5Y
13.81% 11.21%
EPS Y/Y TTM
60.02%
Sales Y/Y TTM
22.41%
EPS Q/Q
213.33%
Sales Q/Q
18.15%
Earnings
Nov 10 AMC
EPS/Sales Surpr.
100.00% 2.12%
Insider Own
6.76%
Insider Trans
2.00%
Inst Own
54.96%
Inst Trans
0.12%
ROA
-6.80%
ROE
-10.52%
ROIC
-8.75%
Gross Margin
60.67%
Oper. Margin
-3.66%
Profit Margin
-4.03%
SMA20
1.58%
SMA50
1.25%
SMA200
-19.63%
Trades
Shs Outstand
46.15M
Shs Float
43.05M
Short Float
2.00%
Short Ratio
3.87
Short Interest
0.86M
52W High
6.61 -52.18%
52W Low
2.86 10.49%
Volatility
7.43% 5.51%
ATR (14)
0.17
RSI (14)
51.80
Beta
0.51
Rel Volume
0.94
Avg Volume
222.67K
Volume
209,157
Perf Week
1.94%
Perf Month
6.40%
Perf Quarter
-4.24%
Perf Half Y
-21.00%
Perf YTD
-45.61%
Perf Year
-19.39%
Perf 3Y
47.66%
Perf 5Y
12.06%
Perf 10Y
579.57%
Recom
1.50
Target Price
6.25
Prev Close
3.23
Price
3.16
Change %
-2.17%
Consensus
Buy
Avg. Price Target
$6.25
Implied Upside
+97.8%
Analysts5incl. previous ratings
Rating Distribution4 Buy · 1 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Feb 14, 2025Downgrade
PPiper Sandler
Overweight → Neutral$4.50+42.4%
Jul 25, 2024Resumed
RILY logoRB. Riley Securities
Buy$4+26.6%
Sep 07, 2023Initiated
LLake Street
Buy$4+26.6%
Sep 07, 2023Initiated
RILY logoRB. Riley Securities
Buy$4.50+42.4%
Nov 10, 2022Upgrade
PPiper Sandler
Neutral → Overweight$3 → $3.50+10.8%
Nov 10, 2022Upgrade
CCanaccord Genuity
Hold → Buy$3 → $4+26.6%
Jan 26, 2021Downgrade
PPiper Sandler
Overweight → Neutral$9 → $4.50+42.4%
Jan 26, 2021Downgrade
CCanaccord Genuity
Buy → Hold$5+58.2%
Aug 10, 2020Initiated
HH.C. Wainwright
Buy$16+406.3%
Jul 16, 2020Initiated
CCanaccord Genuity
Buy$13+311.4%
Show Previous News
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KALBERMATTEN ADAM RChief Commercial OfficerSep 08 '26Buy3.1632,000101,120394,017Sep 09 04:32 PM
KALBERMATTEN ADAM RChief Commercial OfficerJul 28 '26Option Exercise0.0075,0000387,500Aug 06 04:11 PM
KALBERMATTEN ADAM ROfficerAug 03 '26Proposed Sale4.2625,483108,629Aug 03 05:18 PM
KALBERMATTEN ADAM RPresident-Chief Commercial OffJun 11 '26Buy3.9412,50049,275312,500Jun 15 04:34 PM
Schiller EricChief Technology OfficerMay 18 '26Buy3.915,00019,5625,000May 20 04:41 PM
Tharby Linda MChief Executive OfficerMay 15 '26Buy3.901,1914,645620,622May 20 04:02 PM
Tharby Linda MChief Executive OfficerMay 14 '26Option Exercise0.0013,9770626,757May 19 05:08 PM
Pazdan ChristopherChief Operating OfficerMay 14 '26Option Exercise0.005,3270310,458May 18 04:39 PM
Pazdan ChristopherChief Operating OfficerMay 14 '26Buy3.885,00019,400305,131May 18 04:35 PM
Adams Thomas EdwardChief Financial OfficerMay 14 '26Option Exercise0.008,1930316,340May 18 04:33 PM
Adams Thomas EdwardChief Financial OfficerMay 14 '26Buy3.865,50021,248308,147May 18 04:31 PM
Tharby Linda MOfficerMay 14 '26Proposed Sale3.957,32628,915May 14 05:01 PM
Pazdan ChristopherChief Operating OfficerMar 16 '26Option Exercise0.005,06405,064Mar 18 04:47 PM
Adams Thomas EdwardChief Financial OfficerMar 16 '26Option Exercise0.005,40405,404Mar 18 04:45 PM
Tharby Linda MChief Executive OfficerMar 16 '26Option Exercise0.0015,968015,968Mar 18 04:42 PM
KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Mahwah, NJ.
President & CEOMr. Adam Kalbermatten
CFOMr. Thomas Adams
Chief Operating OfficerMr. Christopher Pazdan
Chief Technology OfficerMr. Eric Schiller
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)